Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Wang X, Han W, Zhang W, Wang X, Ge X, Lin Y, Zhou H, Hu M, Wang W, Liu K, Lu J, Qie S, Zhang J, Deng W, Wang L, Han C, Li M, Zhang K, Li L, Wang Q, Shi H, Yu Z, Zhao Y, Sun X, Shi Y, Pang Q, Zhou Z, Liang J, Chen D, Feng Q, Bi N, Zhang T, Deng L, Wang W, Liu W, Wang J, Zhai Y, Wang J, Chen W, Chen J, Xiao Z; Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG). Wang X, et al. Among authors: yu z. JAMA Netw Open. 2023 May 1;6(5):e2312625. doi: 10.1001/jamanetworkopen.2023.12625. JAMA Netw Open. 2023. PMID: 37195667 Free PMC article. Clinical Trial.
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.
Chang X, Deng W, Wang X, Zhou Z, Yang J, Guo W, Liu M, Qi X, Li L, Zhang K, Zhang M, Shi Y, Liu K, Zhao Y, Wang H, Yu Z, Zhang J, Wang L, Qiao X, Han C, Zhu S, Zhang R, Chen J, Hu C, Zhang F, Hou X, Pang Q, Zhang W, Li G, Lin H, Sun X, Ge X, Li C, Ge H, Li D, Wang Y, Lu N, Gao X, Qin S, Tian Y, Xiao Z. Chang X, et al. Among authors: yu z. Radiat Oncol. 2021 Jun 9;16(1):102. doi: 10.1186/s13014-020-01691-4. Radiat Oncol. 2021. PMID: 34107984 Free PMC article.
Comprehensive Target Engagement by the EZH2 Inhibitor Tulmimetostat Allows for Targeting of ARID1A Mutant Cancers.
Keller PJ, Adams EJ, Wu R, Côté A, Arora S, Cantone N, Meyer R, Mertz JA, Gehling V, Cui J, Stuckey JI, Khanna A, Zhao F, Chen Z, Yu Z, Cummings R, Taimi M, Lakhani NJ, Rasco DW, Gutierrez M, Duska L, Devitt M, Rippley R, Levell J, Truong J, Wang J, Sun K, Trojer P. Keller PJ, et al. Among authors: yu z. Cancer Res. 2024 Jun 4. doi: 10.1158/0008-5472.CAN-24-0398. Online ahead of print. Cancer Res. 2024. PMID: 38833522
21,363 results
You have reached the last available page of results. Please see the User Guide for more information.